טוען...
Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies
BACKGROUND: To assess the efficacy and safety of treatment with abiraterone acetate (AA) in chemotherapy-naïve men with metastatic castration-resistant prostate cancer (mCRPC) in the ‘real-life’ setting. METHODS: Data acquisition on the outcomes of the use of AA in chemotherapy-naive patients with m...
שמור ב:
| הוצא לאור ב: | Ther Adv Urol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120185/ https://ncbi.nlm.nih.gov/pubmed/30186368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287218786160 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|